363 related articles for article (PubMed ID: 10516348)
1. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
Manns BJ; Burgess ED; Hyndman ME; Parsons HG; Schaefer JP; Scott-Douglas NW
Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348
[TBL] [Abstract][Full Text] [Related]
2. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
Weger M; Stanger O; Deutschmann H; Temmel W; Renner W; Schmut O; Semmelrock J; Haas A
Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):286-90. PubMed ID: 11981642
[TBL] [Abstract][Full Text] [Related]
3. Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine.
Ducloux D; Fournier V; Rebibou JM; Bresson-Vautrin C; Gibey R; Chalopin JM
Clin Nephrol; 1998 Apr; 49(4):232-5. PubMed ID: 9582553
[TBL] [Abstract][Full Text] [Related]
4. Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis.
Lee YK; Kwon YJ; Yoon JW; Oh KS; Cha DR; Cho WY; Huh K; Pyo HJ; Kim HK
J Korean Med Sci; 1999 Apr; 14(2):193-8. PubMed ID: 10331567
[TBL] [Abstract][Full Text] [Related]
5. Homocyst(e)ine metabolism in hemodialysis patients treated with vitamins B6, B12 and folate.
Henning BF; Zidek W; Riezler R; Graefe U; Tepel M
Res Exp Med (Berl); 2001 Mar; 200(3):155-68. PubMed ID: 11426667
[TBL] [Abstract][Full Text] [Related]
6. Oral vitamin B(12) and high-dose folic acid in hemodialysis patients with hyper-homocyst(e)inemia.
Manns B; Hyndman E; Burgess E; Parsons H; Schaefer J; Snyder F; Scott-Douglas N
Kidney Int; 2001 Mar; 59(3):1103-9. PubMed ID: 11231366
[TBL] [Abstract][Full Text] [Related]
7. Hyperhomocyst(e)inemia--determining factors and treatment.
Genest J
Can J Cardiol; 1999 Apr; 15 Suppl B():35B-38B. PubMed ID: 10350684
[TBL] [Abstract][Full Text] [Related]
8. Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study.
Langman LJ; Ray JG; Evrovski J; Yeo E; Cole DE
Arch Intern Med; 2000 Apr; 160(7):961-4. PubMed ID: 10761961
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocyst(e)inemia and risk of ischemic stroke among young Asian adults.
Tan NC; Venketasubramanian N; Saw SM; Tjia HT
Stroke; 2002 Aug; 33(8):1956-62. PubMed ID: 12154245
[TBL] [Abstract][Full Text] [Related]
10. Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys.
Lentz SR; Malinow MR; Piegors DJ; Bhopatkar-Teredesai M; Faraci FM; Heistad DD
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2930-4. PubMed ID: 9409278
[TBL] [Abstract][Full Text] [Related]
11. [Hyperhomocyst(e)inemia--an independent risk factor of stroke].
Lalouschek W; Aull S; Deecke L; Schnider P; Uhl F; Zeiler K
Fortschr Neurol Psychiatr; 1996 Jul; 64(7):271-7. PubMed ID: 8765893
[TBL] [Abstract][Full Text] [Related]
12. Rationale and design for the CARDIOVIT Study (Cardiovit, Atherosclerotic vascular disease and hypeRhomocysteinemia: an epiDemiological study in Indians, additionally evaluating the effect of Oral VITamin supplementation).
Shenoy KT; Lena KB; Sali N; Syam S; Shenoy ST; Rajadhyaksha VD; Pai GP; Shaikh AA;
Curr Med Res Opin; 2006 Apr; 22(4):641-8. PubMed ID: 16684424
[TBL] [Abstract][Full Text] [Related]
13. Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background.
Moghadasian MH; McManus BM; Frohlich JJ
Arch Intern Med; 1997 Nov; 157(20):2299-308. PubMed ID: 9361570
[TBL] [Abstract][Full Text] [Related]
14. Homocyst(e)ine, vitamins and genetic interactions in vascular disease.
Malinow MR
Can J Cardiol; 1999 Apr; 15 Suppl B():31B-34B. PubMed ID: 10350683
[TBL] [Abstract][Full Text] [Related]
15. Oral folate reduces plasma homocyst(e)ine levels in hemodialysis patients with cardiovascular disease.
Stanford JL; Molina H; Phillips J; Kohlman-Trigoboff D; Moore J; Smith BM
Cardiovasc Surg; 2000 Dec; 8(7):567-71. PubMed ID: 11068219
[TBL] [Abstract][Full Text] [Related]
16. Hyperhomocyst(e)inemia is associated with carotid atherosclerosis.
Lupattelli G; Rufini S; Locati EH; Lombardini R; Ciuffetti G; Siepi D; Mannarino E
Angiology; 1999 Oct; 50(10):823-30. PubMed ID: 10535721
[TBL] [Abstract][Full Text] [Related]
17. Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis.
Yoo JH; Chung CS; Kang SS
Stroke; 1998 Dec; 29(12):2478-83. PubMed ID: 9836754
[TBL] [Abstract][Full Text] [Related]
18. Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial.
Sesmilo G; Biller BM; Llevadot J; Hayden D; Hanson G; Rifai N; Klibanski A
J Clin Endocrinol Metab; 2001 Apr; 86(4):1518-24. PubMed ID: 11297577
[TBL] [Abstract][Full Text] [Related]
19. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
Stühlinger MC; Stanger O
Curr Drug Metab; 2005 Feb; 6(1):3-14. PubMed ID: 15720202
[TBL] [Abstract][Full Text] [Related]
20. Hyperhomocystinemia and the prevalence of symptomatic atherosclerotic vascular disease in Taiwanese chronic hemodialysis patients: a retrospective study.
Chuang FR; Fang JT; Chen JB; Lin CL; Chen HY; Lee CN; Wang PH; Lee CH
Ren Fail; 2003 Sep; 25(5):765-74. PubMed ID: 14575285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]